| Literature DB >> 16326226 |
Abstract
Over the past 20 years, a link between lipoprotein disorders and atherosclerosis, and its clinical manifestations of myocardial infarction, stroke, and sudden cardiac death, has been conclusively demonstrated. This article reviews lipoprotein metabolism, its pathophysiology, describes an approach for the management of patients with lipid disorders and discusses therapy using the ATP III guidelines.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16326226 DOI: 10.1016/j.pop.2005.09.002
Source DB: PubMed Journal: Prim Care ISSN: 0095-4543 Impact factor: 2.907